This online article, written in Spanish, summarizes a review of research evidence conducted to determine whether risperidone, an antipsychotic medication, is effective in treating symptoms and behavior in people on the autism spectrum. The review concludes that risperidone may reduce irritability, repetitive behavior, and hyperactivity in some people on the autism spectrum. However, the authors also note that there are side-effects including weight gain, and they suggest that further research is needed to compare long-term benefits and risks.

This resource is available in Chinese, English, French, and Spanish.

Cochrane is a “global independent network of researchers, professionals, patients, carers, and people interested in health.” [Website] The network reviews evidence about health treatments.